Acta Veterinaria et Zootechnica Sinica ›› 2024, Vol. 55 ›› Issue (1): 271-281.doi: 10.11843/j.issn.0366-6964.2024.01.025

• PREVENTIVE VETERINARY MEDICINE • Previous Articles     Next Articles

Prokaryotic Expression, Polyclonal Antibody Preparation and Activity Identification of Helicase RuvA from Mycoplasma hyopneumoniae

XIE Qingyun1,3, XING Huixuan1,2, YU Yanfei1,3, YUAN Ting1,3, XIONG Qiyan1,3, XIONG Fuqiang2,4*, FENG Zhixin1,2,3,4*   

  1. 1. Key Laboratory of Veterinary Biological Engineering and Technology, Ministry of Agriculture/Institute of Veterinary Medicine, Jiangsu Academy of Agricultural Sciences, Nanjing 210014, China;
    2. College of Animal Science, Tibet Agricultural and Animal Husbandry University, Linzhi 850400, China;
    3. GuoTai (Taizhou) Center of Technology Innovation for Veterinary Biologicals, Taizhou 225300, China;
    4. College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210095, China
  • Received:2023-04-13 Online:2024-01-23 Published:2024-01-24

Abstract: Homologous recombination mediated antigenic variation plays an important role in the frequent persistent infection of Mycoplasma hyopneumoniae of pigs. Allosteric regulation of Holliday junctions by helicase RuvA is a key step involved in homologous recombination. Given that, this study aims at expressing RuvAMhp recombinant protein, identifying its DNA binding activity and preparing polyclonal antibody against RuvAMhp. Prokaryotic expression plasmid pET21a-RuvA was constructed by molecular cloning. Following expression induction and purification, the RuvAMhp recombinant protein was obtained; The polyclonal antibody against RuvAMhp was prepared by immunizing rabbit, and the titer and specificity were determined by indirect ELISA and Western blot; The DNA binding activity of RuvAMhp was analyzed by electrophoretic mobility shift assay and surface plasmon resonance technique; The oligomerization of RuvAMhp was determined by electrophoretic mobility shift assay combined Western blot. RuvAMhp recombinant protein expressed by prokaryotic expression was about 26 ku; The prepared polyclonal antibody against RuvAMhp had good specificity and high titer of 1:256 000; RuvAMhp has strong DNA binding activity with an affinity of 624.4 pmol·L-1 (KD) for Holliday junctions, and forms stable complexes with it mainly in octamers. In this study, the prokaryotic expression, polyclonal antibody preparation and activity identification of RuvAMhp were achieved, which laid a foundation for further exploration of the molecular mechanism of helicase RuvA mediating antigenic variation of Mycoplasma hyopneumoniae by homologous recombination regulation.

Key words: Mycoplasma hyopneumoniae, helicase RuvA, DNA binding, polyclonal antibody

CLC Number: